Clinical trial
A Phase I Study of ECO-4601 in Patients With Advanced Cancer
NCT00338026 · Thallion Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00338026 |
|---|---|
| Title | A Phase I Study of ECO-4601 in Patients With Advanced Cancer |
| Official title | A Phase I, Dose Finding, Pharmacokinetic, and Safety Study of Continuous IV Infusion of ECO-4601 in Patients With Advanced Cancer Including an Extension Portion to Obtain Safety Data at the Highest Tolerable Dose |
| Lead sponsor | Thallion Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tumors, Glioma, Colorectal Cancer, Lung Cancer, Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer |
| Intervention type | Drug |
| Interventions | ECO-4601 |
| Enrollment | 26 |
| Start date | Feb 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jun 20, 2006 |
| Last update posted | Jul 15, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: